Compositions of herbal formulations and uses thereof
Disclosed herein are herbal formulations for relief from symptoms of skin disease. The formulations can also be combined with an active or inactive pharmaceutical ingredient, and/or a pharmaceutically acceptable excipient.
1. A method of reducing symptoms associated with a skin condition in a subject, comprising identifying the subject in need thereof and administering to the subject an effective amount of a composition comprising a mixture of plant extracts, wherein the extracts are obtained from the following plants:
Althaea officinalis; Ervum lens; Populas alba; Populus tremuloides; Conium maculatium; Sambucus nigra; Hamamelis virginiana ; and Phytolacca decendra; Conium maculatium; Phytolacca decendra; Pimpinella saxifraga; Rhus toxicodendron ; and Vincetoxicum officinale; Avena sativa; Aesculus hippocastanum; Capsella Bursa Pastoris; Hamamelis virginiana; Hydrastis canadensis; Achillea millefolium ; and Sanguinaria Canadensis ; and Berberis vulgaris; Matricaria chamomilla; Cochlearia officinalis; Hydrastis canadensis; Nasturtium officinale; Scrophularia nodosa; Smilax medica; Tussilago farfara ; and Veronica officinalis ; and
wherein the skin condition is associated with acne vulgaris, psoriasis, eczema, or atopic dermatitis, or the skin condition is pruritis, erythema, or excoriations.
2. The method of claim 1 , wherein the composition comprises herbal extracts present in the following amount (w/w): Achillea millefolium from about 0.01% to about 20%; Aesculus hippocastanum from about 0.01% to about 20%; Althaea officinalis from about 0.01% to about 20%; Avena sativa from about 0.01% to about 25%; Berberis vulgaris from about 0.01% to about 20%; Capsella Bursa Pastoris from about 0.01% to about 20%; Cochlearia officinalis from about 0.01% to about 20%; Conium maculatium from about 0.01% to about 35%; Ervum lens from about 0.01% to about 20%; Hamamelis virginiana from about 0.01% to about 25%; Hydrastis canadensis from about 0.01% to about 20%; Matricaria chamomilla from about 0.01% to about 20%; Nasturtium officinale from about 0.01% to about 15%; Phytolacca decendra from about 0.01% to about 20%; Pimpinella saxifraga from about 0.01% to about 20%; Populas alba from about 0.01% to about 20%; Populus tremuloides from about 0.01% to about 20%; Rhus toxicodendron from about 0.01% to about 25%; Sambucus nigra from about 0.01% to about 20; Sanguinaria Canadensis from about 0.01% to about 20%; Scrophularia nodosa from about 0.01% to about 20%; Smilax medica from about 0.01% to about 20%; Tussilago farfara from about 0.01% to about 15%; Veronica officinalis from about 0.01% to about 15%; and Vincetoxicum officinale from about 0.01% to about 15%.
3. The method of claim 1 , wherein the composition comprises about 0.01% or more (w/w) of the following herbal extracts: Althaea officinalis; Ervum lens; Populas alba; Populus tremuloides; Conium maculatium; Sambucus nigra; Hamamelis virginiana ; and Phytolacca decendra; Conium maculatium; Phytolacca decendra; Pimpinella saxifraga; Rhus toxicodendron ; and Vincetoxicum officinale; Avena sativa; Aesculus hippocastanum; Capsella Bursa Pastoris; Hamamelis virginiana; Hydrastis canadensis; Achillea millefolium ; and Sanguinaria Canadensis ; and Berberis vulgaris; Matricaria chamomilla; Cochlearia officinalis; Hydrastis canadensis; Nasturtium officinale; Scrophularia nodosa; Smilax medica; Tussilago farfara ; and Veronica officinalis.
4. The method of claim 1 , wherein the composition further comprises a physiologically acceptable carrier, diluent, or excipient.
5. The method of claim 1 , wherein the composition is formulated for topical application.
6. The method of claim 1 , wherein the composition is an aqueous solution.